Detalhe da pesquisa
1.
A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer.
Clin Cancer Res
; 22(10): 2368-76, 2016 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26644411
2.
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.
Clin Cancer Res
; 19(5): 1232-43, 2013 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23434733